Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A combination histamine-1 receptor antagonist and a corticosteroid nasal spray has been approved by the FDA for the treatment of seasonal allergic rhinitis.

Azelastine HCl and Fluticasone Propionate Nasal Spray (Dymista™)